Table 1 Baseline demographics and clinical characteristics of follow-up participants and non-responders to follow-up.
From: Long term follow-up of a randomised controlled trial of services for urinary symptoms
| Â | RESPONDERS | NON- RESPONDERS | ||||
|---|---|---|---|---|---|---|
| Â | Baseline characteristics of responders at 6 years | Baseline characteristics of responders at 6 years | Non-responders to follow-up | Do not mail | Migrants | Deaths |
| Â | Intervention | Standard care | Â | Â | Â | Â |
Number of patients | 2133 | 595 | 389 | 107 | 190 | 332 |
Age group in years | Â | Â | Â | Â | Â | Â |
40-49 (%) | 429 (20%) | 125 (21%) | 110 (29%) | 14 (13%) | 49 (26%) | 7 (2%) |
50-59 (%) | 644 (30%) | 164 (27%) | 110 (29%) | 40 (37%) | 61 (32%) | 25 (7%) |
60-69 (%) | 638 (30%) | 183 (31%) | 72 (19%) | 37 (35%) | 46 (24%) | 70 (21%) |
70-79 (%) | 368 (17%) | 106 (18%) | 69 (18%) | 13 (12%) | 27 (14%) | 139 (42%) |
> 80 (%) | 54 (3%) | 17 (3%) | 28 (7%) | 3 (3%) | 7 (4%) | 91 (27%) |
Female (%) | 1351 (63%) | 360 (60%) | 259 (67%) | 70 (65%) | 129 (68%) | 130 (39%) |
Ethnic group | Â | Â | Â | Â | Â | Â |
white (%) | 2029 (95%) | 561 (94%) | 346 (89%) | 92 (86%) | 181 (95%) | 324 (98%) |
Long-term illness (%) | 773 (36%) | 211 (35%) | 149 (38%) | 43 (40%) | 58 (31%) | 187 (56%) |
Symptoms | Â | Â | Â | Â | Â | Â |
Leakage | 1713 (80%) | 470 (79%) | 324 (83%) | 89 (83%) | 158 (83%) | 256 (77%) |
Frequency | 1121 (52%) | 280 (47%) | 219 (56%) | 49 (46%) | 99 (52%) | 171 (51%) |
Urgency | 1359 (64%) | 401 (67%) | 262 (67%) | 67 (63%) | 115 (60%) | 252 (76%) |
Nocturia | 714 (33%) | 205 (34%) | 144 (37%) | 35 (33%) | 66 (35%) | 191 (57%) |
Mild or no problem | 1158 (54%) | 326 (55%) | 190 (49%) | 63 (59%) | 101 (53%) | 149 (45%) |
Impact-Median (IQR) | 5 (2, 10) | 4 (2, 9) | 6 (2, 11) | 5 (2, 11) | 5 (3, 11) | 4 (1, 10) |
Satisfied with current urinary symptoms for rest of life | 666 (31%) | 212 (36%) | 92 (24%) | 26 (24%) | 52 (27%) | 110 (33%) |